Performance Grant. Pursuant to the Plan, [Insert Number] Performance Share Units (“Target Amount”) were awarded to the Participant on February XX, 2024 (“Date of Grant”), subject to the terms and conditions of the Plan, and subject further to the terms and conditions set forth in this Agreement and Exhibit A attached hereto. Each Performance Share Unit represents the right to receive a cash payment equivalent to the Fair Market Value of one share of Company Stock if the Performance Goals set forth in Section 4 and Exhibit A for the Performance Period are fulfilled. The actual number of Performance Share Units that may be earned may be from 0% to 200% of the Target Amount, depending on the achievement of the Performance Goals. The Performance Period for purposes of this Agreement is the period beginning on January 1, 2024 and ending on December 31, 2026.
Performance Grant. Pursuant to the Plan, the Participant is granted a Performance Award at a Target Amount of on , subject further to the terms and conditions set forth herein. The actual payout may be from 0% to 200% of the Target Amount. Payment will be made by March 15, 2008.
Performance Grant. The Company shall grant Executive a stock option to purchase 500,000 shares of Common Stock at an exercise price of $1.65 per share (the “Performance Option”). The Performance Option shall be governed by the Plan. For so long as the Executive is an employee of the Company, the Performance Option shall vest, if at all, upon the following milestones being achieved: · 150,000 upon: (i) the Company’s Common Stock becoming listed on a national exchange or on the Over-the-Counter Bulletin Board; and (ii) the enrollment of the first patient in a Phase 1 clinical trial for G-202. · 200,000 upon: (i) enrollment of first patient in a second Phase 1 clinical trial; (ii) enrollment of first patient in a Phase II clinical trial or an expanded cohort in a Phase 1B clinical trial; or (iii) enrollment of tenth patient in a Phase II clinical trial or in an expanded cohort in a phase 1B clinical trial. · 150,000 upon an additional: (i) enrollment of first patient in a second Phase 1 clinical trial; (ii) enrollment of first patient in a Phase II clinical trial or an expanded cohort in a Phase 1B clinical trial; or (iii) enrollment of tenth patient in a Phase II clinical trial or in an expanded cohort in a phase 1B clinical trial. (for purposes of clarity, these milestones are in additional to those required for the vesting of options to purchase 200,000 shares of Common Stock as contained in the paragraph immediately above) Subject to any applicable acceleration provisions contained in this Agreement or the Severance Agreement, upon termination of Executive’s employment with the Company, Executive’s rights to any portion of the Performance Option that has not yet vested as of the date of such termination shall not vest and all of Executive’s rights to such unvested portion of the Option shall terminate. In the event of a Change of Control (as such term is defined in the Plan), the entire Option shall vest and become immediately exercisable. The Option shall have a term of 7 years from date of grant. The vested Performance Options shall remain exercisable for: (i) the remaining term of the option if Executive is no longer employed by the Company as a result of terminated without Cause or with Good Reason. In the event Executive is no longer employed for any other reason such as death or disability, the terms of the Plan shall govern. In connection with such grant, the Executive shall enter into the Company’s standard stock option agreement which will incorporate the foregoing...
Performance Grant. The Enterprise will only be entitled to receive the Performance Grant Amount once documentation is provided to the Panel's satisfaction to confirm the completion of the Project by the Project Completion Date. The Enterprise is required to purchase External Capability Building Services within 6 months of receipt of Project Funds.
Performance Grant. (i) The Company shall request that the CCLG authorize and grant Employee 212,500 restricted share units (“Performance Grant” and, together with the Time-Based Grant, the “Grants”) of Lions Gate Entertainment Corp. in accordance with the Plan. Employee acknowledges that this Performance Grant of stock is subject to the approval of the CCLG.
Performance Grant. In fiscal years 2012, 2013, 2014 and 2015, you will be eligible to receive an annual target bonus grant of options to purchase One Hundred Twenty Five Thousand (125,000) shares of the Company’s Common Stock each year at an exercise price based on the fair market value of the Company’s common stock on the date of the grant, based upon the achievement each year of twenty percent (20%) annual organic EBITDA growth, excluding growth from making acquisitions of companies and other revenue producing assets. In the event of a Change of Control (as defined below) of the Company (or its successor), upon the closing of such Change of Control, all performance shares previously earned as of the date of Change of Control shall become vested. All of your options will have a cashless exercise feature.
Performance Grant. Effective as of the date hereof, Parent shall grant to Employee (the “Performance Grant”) 262,500 restricted Mr. Jxxxxx Xxxxx September 10, 2007 Page 7 of 20 shares units (the “Performance RSUs”, and with the Time-Based RSUs, the “RSUs”) of Parent in accordance with the terms and conditions of the Lions Gate Entertainment Corp. Performance Share Unit Award Agreement being entered by Parent and Employee concurrently herewith.
Performance Grant. At such time as Physio has purchased one thousand (1,000) Products or has sold one thousand (1,000) Defibrillator-Monitors which include the Software Technology (or a combination of both totaling 1,000), Cardiac Science will issue a warrant to Physio to purchase an additional two hundred thousand (200,000) shares of common stock in Cardiac Science at a price of three dollars ($3.00) per share. The warrant on this performance grant must be exercised by Physio, if at all, within two (2) years of the date of the grant. Any share issued pursuant to this performance grant will also include "piggyback" registration rights.
Performance Grant. On the Effective Date, Executive will be granted one hundred and twenty-five thousand (125,000) restricted shares of Company Common Stock (the “Performance Grant”). Fifty percent (50%) of the Performance Grant will vest only if Executive remains employed with the Company through the first anniversary of the grant date and only if the Company reports four consecutive quarters of cumulative non-GAAP operating profitability following the Effective Date and on or prior to April 1, 2015. The remaining fifty percent (50%) of the Performance Grant will vest only if Executive remains employed with the Company through the second anniversary of the grant date and only if the Company reports a completed Company fiscal year with non-GAAP operating profit equal to or exceeding five percent (5%) of the Company’s GAAP annual revenue following the Effective Date and on or prior to April 1, 2015. In the event that some or all of the performance criteria in the preceding two sentences are not satisfied on or prior to April 1, 2015, the unvested shares subject to the Performance Grant shall expire unvested and be forfeited and automatically transferred to and reacquired by the Company at no cost to the Company, unless the Board, in its sole discretion based upon the facts and circumstances, elects to treat all or a portion of the performance criteria satisfied with respect to such unvested shares and cause all or a portion of the unvested Performance Grant to become vested on such date. For the purpose of calculating non-GAAP operating profit, the Company’s GAAP operating profit shall be adjusted in the manner the Company uses for publicly reporting non-GAAP financial measures and shall exclude equity compensation expenses and any other extraordinary and one-time expenses, as reasonable determined by the Compensation Committee of the Board. Each tranche of the Performance Grant shall vest on the first date that both the service-based vesting requirement and the profit-based metric are attained. In all events, the vesting of the Performance Grant is further subject to Executive remaining employed with the Company through the vesting date; provided, however, in the event of a termination of employment either by the Company without Cause or by the Executive for Good Reason all unvested shares subject to the Performance Grant as of Executive’s termination date shall remain outstanding in escrow but unvested until the three (3) month anniversary of such termination. In the event ...
Performance Grant. Hooker Furniture Corporation (the “Company”) hereby grants to you a Performance Grant based on the terms of this Grant Agreement. The Performance Grant entitles you to payment of a designated amount if and to the extent certain Performance Goals are achieved for the Performance Period. The Performance Grant is subject to terms and conditions set forth herein, including the terms set forth in the 2010 Amendment and Restatement of the Hooker Furniture Corporation Stock Incentive Plan (the “Plan”). By signing below, you acknowledge that you agree to be bound by all the terms and conditions hereof and of the Plan with respect to this Performance Grant. In the event of any conflict between the terms of this Grant Agreement and the terms of the Plan, the terms of the Plan shall control. Capitalized terms not defined in this Grant Agreement shall have the meanings set forth in the Plan.
